Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2008 1
2009 1
2014 3
2015 3
2016 4
2017 3
2018 2
2019 1
2021 2
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Reduced G protein signaling despite impaired internalization and β-arrestin recruitment in patients carrying a CXCR4Leu317fsX3 mutation causing WHIM syndrome.
Kumar R, Milanesi S, Szpakowska M, Dotta L, Di Silvestre D, Trotta AM, Bello AM, Giacomelli M, Benedito M, Azevedo J, Pereira A, Cortesao E, Vacchini A, Castagna A, Pinelli M, Moratto D, Bonecchi R, Locati M, Scala S, Chevigné A, Borroni EM, Badolato R. Kumar R, et al. Among authors: cortesao e. JCI Insight. 2023 Mar 8;8(5):e145688. doi: 10.1172/jci.insight.145688. JCI Insight. 2023. PMID: 36883568 Free PMC article.
Oxidative Stress Parameters Can Predict the Response to Erythropoiesis-Stimulating Agents in Myelodysplastic Syndrome Patients.
Gonçalves AC, Alves R, Baldeiras I, Jorge J, Marques B, Paiva A, Oliveiros B, Cortesão E, Nascimento Costa JM, Sarmento-Ribeiro AB. Gonçalves AC, et al. Among authors: cortesao e. Front Cell Dev Biol. 2021 Jun 7;9:701328. doi: 10.3389/fcell.2021.701328. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34164406 Free PMC article.
[Serum Erythropoietin as Prognostic Marker in Myelodysplastic Syndromes].
Cortesão E, Tenreiro R, Ramos S, Pereira M, César P, Carda JP, Gomes M, Rito L, Magalhães E, Gonçalves AC, Silva NC, Geraldes C, Pereira A, Ribeiro L, Nascimento Costa JM, Ribeiro AB. Cortesão E, et al. Acta Med Port. 2015 Nov-Dec;28(6):720-5. Epub 2015 Dec 31. Acta Med Port. 2015. PMID: 26849756 Free article. Portuguese.
Clonal shifts in MDS - from SF3B1 to EZH2.
Barbosa Ribeiro A, Coucelo M, Tenreiro R, Simões AT, Marques G, Ribeiro L, Cortesão E, Sarmento-Ribeiro AB. Barbosa Ribeiro A, et al. Among authors: cortesao e. Leuk Lymphoma. 2018 Dec;59(12):2994-2997. doi: 10.1080/10428194.2018.1443452. Epub 2018 Apr 4. Leuk Lymphoma. 2018. PMID: 29616853 No abstract available.
Genetic variants involved in oxidative stress, base excision repair, DNA methylation, and folate metabolism pathways influence myeloid neoplasias susceptibility and prognosis.
Gonçalves AC, Alves R, Baldeiras I, Cortesão E, Carda JP, Branco CC, Oliveiros B, Loureiro L, Pereira A, Nascimento Costa JM, Sarmento-Ribeiro AB, Mota-Vieira L. Gonçalves AC, et al. Among authors: cortesao e. Mol Carcinog. 2017 Jan;56(1):130-148. doi: 10.1002/mc.22478. Epub 2016 Mar 7. Mol Carcinog. 2017. PMID: 26950655
Real life experience with frontline azacitidine in a large series of older adults with acute myeloid leukemia stratified by MRC/LRF score: results from the expanded international E-ALMA series (E-ALMA+).
Falantes J, Pleyer L, Thépot S, Almeida AM, Maurillo L, Martínez-Robles V, Stauder R, Itzykson R, Pinto R, Venditti A, Bargay J, Burgstaller S, Martínez MP, Seegers V, Cortesão E, Foncillas MÁ, Gardin C, Montesinos P, Musto P, Fenaux P, Greil R, Sanz MA, Ramos F; European ALMA + Investigators. Falantes J, et al. Among authors: cortesao e. Leuk Lymphoma. 2018 May;59(5):1113-1120. doi: 10.1080/10428194.2017.1365854. Epub 2017 Aug 24. Leuk Lymphoma. 2018. PMID: 28838276
18 results